Correlation Between Pfizer and Luye Pharma
Can any of the company-specific risk be diversified away by investing in both Pfizer and Luye Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Luye Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Luye Pharma Group, you can compare the effects of market volatilities on Pfizer and Luye Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Luye Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Luye Pharma.
Diversification Opportunities for Pfizer and Luye Pharma
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Luye is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Luye Pharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Luye Pharma Group and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Luye Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Luye Pharma Group has no effect on the direction of Pfizer i.e., Pfizer and Luye Pharma go up and down completely randomly.
Pair Corralation between Pfizer and Luye Pharma
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Luye Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.34 times less risky than Luye Pharma. The stock trades about -0.3 of its potential returns per unit of risk. The Luye Pharma Group is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Luye Pharma Group on August 27, 2024 and sell it today you would earn a total of 3.00 from holding Luye Pharma Group or generate 9.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Luye Pharma Group
Performance |
| Timeline |
| Pfizer Inc |
| Luye Pharma Group |
Pfizer and Luye Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Luye Pharma
The main advantage of trading using opposite Pfizer and Luye Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Luye Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Luye Pharma will offset losses from the drop in Luye Pharma's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Luye Pharma vs. Astellas Pharma | Luye Pharma vs. Sanofi ADR | Luye Pharma vs. Amarin PLC | Luye Pharma vs. Novartis AG ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |